Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Oral VK2735

VK2735 for Weight Management Phase 2 (Venture Oral Dosing)

Viking Therapeutics · Phase 2 · Completed · Enrollment 280

NCT06828055

ArmPopulationDoseWeeksEstimandWeight change
Placebo AssignmentObesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #1)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #2)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #3)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #4)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #5)Obesity or overweightn/rn/rn/rn/r
Active Assignment (Dose #6)Obesity or overweightn/rn/rn/rn/r